Add New
    0
    Add New

    Asgard Therapeutics

    Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen-presenting cells. Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy. Asgard Therapeutic’s mission is to pioneer direct cell reprogramming for cancer immunotherapy.

    Description

    SHORT DESCRIPTION:

    Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen-presenting cells. Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy. Asgard Therapeutic’s mission is to pioneer direct cell reprogramming for cancer immunotherapy.

     

    LONG DESCRIPTION:

    Based in

    Lund

    Get Directions
    Nation
    Founded in

    2018

    Founding Status

    $ 5 Millions - $ 10 Millions

    Follow us
    mood_bad
  • No comments yet.
    • Add a review

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    General Rating

    Products / Services

    Pricing

      You May Also Be Interested In

      error: Content protected